CN Patent

CN115043843A — 3-(咪唑并[1,2-b]哒嗪-3-基乙炔基)-4-甲基-n{4-[(4-甲基哌嗪-1-基)甲基]-3-(三氟甲基)苯基}苯甲酰胺和它的单盐酸盐的晶形

Assigned to Takeda Pharmaceuticals USA Inc · Expires 2022-09-13 · 4y expired

What this patent protects

本文公开了3‑(咪唑并[1,2‑b]哒嗪‑3‑基乙炔基)‑4‑甲基‑N‑{4‑[(4‑甲基哌嗪‑1‑基)甲基]‑3‑(三氟甲基)苯基}苯甲酰胺游离碱和3‑(咪唑并[1,2‑b]哒嗪‑3‑基乙炔基)‑4‑甲基‑N‑{4‑[(4‑甲基哌嗪‑1‑基)甲基]‑3‑(三氟甲基)苯基}苯甲酰胺单盐酸盐的新颖晶形、其药物组合物以及它们的制备和使用方法。

USPTO Abstract

本文公开了3‑(咪唑并[1,2‑b]哒嗪‑3‑基乙炔基)‑4‑甲基‑N‑{4‑[(4‑甲基哌嗪‑1‑基)甲基]‑3‑(三氟甲基)苯基}苯甲酰胺游离碱和3‑(咪唑并[1,2‑b]哒嗪‑3‑基乙炔基)‑4‑甲基‑N‑{4‑[(4‑甲基哌嗪‑1‑基)甲基]‑3‑(三氟甲基)苯基}苯甲酰胺单盐酸盐的新颖晶形、其药物组合物以及它们的制备和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN115043843A
Jurisdiction
CN
Classification
—
Expires
2022-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceuticals USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.